Biotecnología
Biotecnología
Biocon Completes Acquisition of Viatris' Global Biosimilars Business
30/11/2022 -
Creates an integrated, leading global biosimilars enterprise with eight commercialized products.
AstraZeneca to Acquire Neogene Therapeutics in $320M Deal
30/11/2022 -
Provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumors.
Quotient Sciences Partners with Emplicure to Manufacture and Study EMPLI03
30/11/2022 -
Emplicure is developing EMPLI03 as an oral buccal tablet with extended-release properties intended for the treatment of moderate to severe pain.
Andelyn Biosciences to Bring First Gene Therapy for Treatment of INAD to Clinical Trials
30/11/2022 -
Infantile Neuroaxonal Dystrophy (INAD) is a rare inherited neurological disorder.
Avectas Expands Collaboration with CCRM and OmniaBio Inc.
30/11/2022 -
Will enable the development of gene-edited induced pluripotent stem cells using Avectas' non-viral cell engineering platform, SOLUPORE.
Charles River Labs Opens Contract Vivarium Space in Chicago
30/11/2022 -
Expands access to AAALAC-accredited, turnkey research program.
Theralink Technologies Achieves CAP Accreditation for Protein Array Lab
30/11/2022 -
Becomes the company's first Reverse Phase Protein Array lab in the U.S. with CAP accreditation for its next-gen proteomic services.
Incannex, Eurofins Enter Development & Mfg. Pact for Addiction Disorder Meds
30/11/2022 -
Eurofins will provide formulation development and manufacture of chewable CannQuit Nicotine (CannQuit-N) and CannQuit Opioid (CannQuit-O).
Integreon Global Appoints Michael Hays as President
30/11/2022 -
Replaces Maurice Barakat, who will assume the role of Executive Chairman and CEO.
Aptamer Group Opens New State-of-the-Art Facilities
30/11/2022 -
New site will help to expand capacity of Aptamer’s Optimer platform to deliver novel binders for the bioprocessing, diagnostic, and drug development sectors.
C4X Discovery, AstraZeneca Enter Potential $402M COPD Alliance
30/11/2022 -
The companies will work to develop C4XD’s NRF2 Activator program in COPD and other inflammatory and respiratory illnesses.
Genezen Appoints Jeff Whitmore as Chief Commercial Officer
30/11/2022 -
Whitmore has 25 years’ experience in biotechnology.
Lonza, AbTis Partner to Extend Bioconjugation Capabilities
30/11/2022 -
To implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox.
Immutep Enters Clinical Trial Collaboration Merck KGaA and Pfizer
30/11/2022 -
To evaluate new combination study of its first-in-class LAG-3 candidate, eftilagimod alpha, and avelumab to treat urothelial cancer.
BigHat Biosciences, Merck Enter AI Research Collaboration
30/11/2022 -
To optimize up to three proteins by leveraging BigHat’s platform to synthesize, express, purify, and characterize molecules.
A World of Virtual Reality: Entering the Metaverse with Bachem 360
23/11/2022 -
Bachem’s virtual showroom sets industry standards in digital customer experience.
Healiva Acquires Cell Therapy Manufacturing Assets from B. Braun
23/11/2022 -
Acquisition will accelerate the launch of Healiva’s personalized skin regeneration therapy, EpiDex.
[WEBINAR] High-Resolution Mass Spectrometry Of Oligonucleotides – Characterization Made Easy
23/11/2022 -
Thursday, December 8, 2022 at 11:30 AM ET
RVAC Medicines and A*STAR Sign Research Collaboration Agreement
23/11/2022 -
Will jointly study and develop solutions to build mRNA manufacturing and analytics capabilities in Singapore.
[WEBINAR] Beyond Automation: Towards a Smart Factory
23/11/2022 -
Thursday, November 17, 2022 at 11:30 AM ET
Nona Biosciences Enters Collaboration Agreement with Dragonfly Therapeutics
23/11/2022 -
Aims to discover and develop fully human heavy chain only antibodies for bispecific/multi-specific therapeutic antibody generation.
